Review
doi: 10.1515/jbcpp.1988.7.1-4.109.
Opioid antagonist-induced upregulation and functional supersensitivity
Affiliations
- PMID: 2854647
- DOI: 10.1515/jbcpp.1988.7.1-4.109
Item in Clipboard
Review
Opioid antagonist-induced upregulation and functional supersensitivity
Rev Clin Basic Pharm.
1988 Jan-Dec.
No abstract available
Similar articles
-
A lack of supersensitivity to opioid receptor agonists following chronic spinal opioid receptor antagonist administration in the rat.Gen Pharmacol. 1995 Jan;26(1):161-8. doi: 10.1016/0306-3623(94)00154-f. Gen Pharmacol. 1995. PMID: 7713356
-
Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors.Addict Biol. 2017 Jul;22(4):1022-1035. doi: 10.1111/adb.12393. Epub 2016 Mar 15. Addict Biol. 2017. PMID: 26990998
-
Chronic opioid antagonist treatment: assessment of receptor upregulation.Eur J Pharmacol. 1989 Nov 7;170(3):193-200. doi: 10.1016/0014-2999(89)90539-6. Eur J Pharmacol. 1989. PMID: 2559854
-
Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents.J Med Chem. 1990 Mar;33(3):895-902. doi: 10.1021/jm00165a002. J Med Chem. 1990. PMID: 2155322 Review. No abstract available.
-
State-of-the-art analgesics from the agonist-antagonist concept.NIDA Res Monogr. 1992;119:71-5. NIDA Res Monogr. 1992. PMID: 1331799 Review. No abstract available.
Cited by
-
Long-acting injectable naltrexone for the management of patients with opioid dependence.Subst Abuse. 2011;5:1-9. doi: 10.4137/SART.S5452. Epub 2011 Feb 6. Subst Abuse. 2011. PMID: 22879745 Free PMC article.
-
Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.Eur J Pharmacol. 2007 Jun 1;563(1-3):92-101. doi: 10.1016/j.ejphar.2007.01.059. Epub 2007 Feb 8. Eur J Pharmacol. 2007. PMID: 17349996 Free PMC article.